Randomized Phase III Trial to Compare the Immunodulatory Effects of Leukine vs. Saline for Early-stage Melanoma Patients Undergoing Sentinel Lymph Node Dissection
Withdrawn prior to enrolment
Phase of Trial: Phase III
Latest Information Update: 03 May 2018
At a glance
- Drugs Sargramostim (Primary) ; Sodium chloride
- Indications Malignant melanoma
- Focus Therapeutic Use
- 26 Apr 2018 Planned End Date changed from 1 Mar 2019 to 8 Aug 2017.
- 26 Apr 2018 Planned primary completion date changed from 1 Mar 2018 to 8 Aug 2017.
- 26 Apr 2018 Status changed from recruiting to withdrawn prior to enrolment.